0120 QT PDev
BioCentury & Getty Images

Product Development

Jan. 20 Quick Takes: AZ, Daiichi get Enhertu approvals in gastric, breast cancer; plus EdiGene, Merck, Oxford, BMS and Omeros 

By stephen hansen, associate editor
Jan 21, 2021 | 2:55 AM GMT

Partners AstraZeneca plc (LSE:AZN; NASDAQ:AZN) and Daiichi

Read the full 408 word article

How to gain access

Continue reading with a
two-week free trial.